ANCHOR CAPITAL ADVISORS LLC
Position in REGN — Regeneron Pharmaceuticals, Inc.
CIK 813933
Boston, MA
Position in REGN
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$1,172,255
-$6,784,391 QoQ
Shares Held
1,880
-81.7% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#614
of 1,322 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026ANCHOR CAPITAL ADVISORS LLC holds $1,172,255 across 1 Biotechnology name. REGN ranks #1 (100.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
1,880 | $1,172,255 |
All Filings in REGN
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,172,255 | 1,880 | Shares | Sole | 2026-08-05 | |
| 2026-03-31 | $7,956,646 | 10,298 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $9,647,603 | 12,499 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $6,633,099 | 11,797 | Shares | Sole | 2025-10-30 | |
| 2025-06-30 | $5,970,300 | 11,372 | Shares | Sole | 2025-08-06 | |
| 2025-03-31 | $6,974,627 | 10,997 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $7,726,643 | 10,847 | Shares | Sole | 2025-02-05 | |
| No filing history on record for this holder in this stock. | ||||||